HAVCR2 and mesothelioma: It has been shown how TIM-3 is commonly found on PD-L1 positive mesothelioma tumors and the improved survival following anti-CTLA4 treatment is associated to a lower expression of TIM-3; as a result, the evaluation of its presence might be a reasonable predictive factor to foresee therapy-responding patients (134).